Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX – Get Free Report)’s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.48 and traded as high as $0.64. Eagle Pharmaceuticals shares last traded at $0.64, with a volume of 215 shares changing hands.
Eagle Pharmaceuticals Stock Performance
The business’s fifty day moving average price is $0.48 and its two-hundred day moving average price is $0.38. The firm has a market capitalization of $8.31 million, a P/E ratio of 0.54 and a beta of 0.83.
Eagle Pharmaceuticals Company Profile
Eagle Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Woodcliff Lake, New Jersey, that focuses on the development, manufacturing and commercialization of hospital-administered therapies in the areas of critical care, oncology and rare diseases. Founded in 2007, Eagle has built expertise in complex injectable formulations and orphan drug designation, aiming to address unmet medical needs through both novel products and reformulated generics.
The company’s marketed portfolio in the United States includes Bendeka®, an intravenous formulation of bendamustine for certain types of leukemia and lymphoma; Beleodaq®, approved for relapsed or refractory peripheral T-cell lymphoma; and Empaveli®, a complement inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria.
Recommended Stories
- Five stocks we like better than Eagle Pharmaceuticals
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for Eagle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eagle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
